PMH37 UNITED KINGDOM COST-CONSEQUENCE ANALYSIS OF ARIPIPRAZOLE IN SCHIZOPHRENIA- DIABETES AND CORONARY HEART DISEASE RISK PROJECTIONS (STAR STUDY)
May 1, 2008, 00:00 AM
10.1016/S1098-3015(10)70384-3
https://www.valueinhealthjournal.com/article/S1098-3015(10)70384-3/fulltext
Section Title :
Section Order :
94
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)70384-3&doi=10.1016/S1098-3015(10)70384-3